// App-Quantinova.ai

PB0052 : Assessing Endothelial Activation and Risk of Bleeding in patients receiving VV-ECMO supportive therapy for COVID-19 using non-standard laboratory assays

Researchers

Presenter

  • T. Edwards

Principal Investigators

  • D. White

  • S. Cox-Morton

  • M. Sharp

  • C. Moore

  • M. Besser

  • E. Symington

  • M. Robinson

  • W. Thomas

  • S. MacDonald

Medical Centers

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • Fibrinogen

  • von Willebrand factor

Drug/Treatment

  • Fibrinogen (IV)

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved